A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.

Autor: Bonifacio M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy. massimiliano.bonifacio@univr.it., Scaffidi L; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Miggiano MC; Department of Hematology, San Bortolo Hospital, Vicenza, Italy., Facchinelli D; Department of Hematology, San Bortolo Hospital, Vicenza, Italy., Tosoni L; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Pezone S; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Griguolo D; Hematology Unit, Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste, Italy., Ciotti G; Onco Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy., Danini M; Hematology Unit, Ca' Foncello Hospital, Treviso, Italy., Bernardelli A; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Bresciani R; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Cavraro M; Department of Medicine, Oncology Unit, San Donà di Piave (VE), Italy., Crosera L; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., De March E; Hematology Unit, San Martino Hospital, Belluno, Italy., Dell'Eva M; Hematology and Bone Marrow Transplant Unit, Ospedale Regionale San Maurizio, Bolzano, Italy., Dorotea L; Oncology Unit, Ospedali Riuniti Padova Sud-Schiavonia, Monselice (PD), Italy., Frison L; Hematology Unit, Ospedale Dell'Angelo, Mestre-Venezia, Italy., Furlani L; Oncology Unit, Ospedale Mater Salutis, Legnago (VR), Italy., Gianesello I; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Lovato E; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Marchetti E; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Morelli G; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Mullai R; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Pizzano U; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Zoletto S; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Fanin R; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy., Krampera M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Trentin L; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Calistri E; Onco Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy., Carli G; Department of Hematology, San Bortolo Hospital, Vicenza, Italy., Binotto G; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy., Tiribelli M; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy.
Jazyk: angličtina
Zdroj: Blood cancer journal [Blood Cancer J] 2024 Mar 26; Vol. 14 (1), pp. 53. Date of Electronic Publication: 2024 Mar 26.
DOI: 10.1038/s41408-024-01025-7
Databáze: MEDLINE